6-Nitroindazole CAS 7597-18-4 Kuchena > 98.0% (GC) Factory

Tsanangudzo Pfupi

Kemikari Zita: 6-Nitroindazole

Anoreva zvakafanana: 6-Nitro-1H-Indazole

CAS: 7597-18-4

Kuchena: > 98.0% (GC)

Chitarisiko: Chiedza Yero kusvika Chiedza Bhuruu Powder

High Quality, Commercial Production

Nharembozha/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 6-Nitroindazole (CAS: 7597-18-4) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com

Chemical Properties:

Chemical Name	6-Nitroindazole
Mashoko anoreva zvakafanana	6-Nitro-1H-Indazole;6-Nitro-1(2)H-Indazole;6-Nitro-Indazole
Nhamba yeCAS	7597-18-4
Nhamba yeCAT	RF2675
Stock Status	MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula	C7H5N3O2
Molecular Weight	180.0 kusvika 184.0163.14
Density	1.525
Solubility muHot Methanol	Very Faint Turbidity
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	Yero Yero kusvika kuChiedza Brown Powder
Kuchena / Analysis Method	>98.0% (GC)
Melting Point	180.0 kusvika 184.0 ℃
Kurasika paKuomesa	<1.00%
Zvose Zvisina Kuchena	<2.00%
Infrared Spectrum	Inopindirana neChimiro
Proton NMR Spectrum	Inopindirana neChimiro
Test Standard	Enterprise Standard
Usage	Pharmaceutical Intermediates

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

Yakakwana Capacity: Inokwana zvivakwa uye matekiniki

Professional Service: Imwe inomira kutenga sevhisi

OEM Package: Tsika pasuru uye label iripo

Fast Delivery: Kana iri mukati me stock, mazuva matatu ekutumira anovimbiswa

Yakagadzika Supply: Chengetedza zvine musoro stock

Tsigiro yehunyanzvi: Tekinoroji mhinduro iripo

Tsika Synthesis Service: Kubva pamagiramu kusvika makirogiramu

Hunhu Hwepamusoro: Yakagadzira yakakwana yemhando yekusimbisa system

FAQ:

Kutenga sei?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com

Makore 15 Oupenyu?Tine makore anopfuura 15 ane ruzivo mukugadzira uye kutumira kunze kwemhando dzakasiyana-siyana dzepamusoro dzemishonga yepakati kana makemikari akanaka.

Main Markets?Tengesa kumusika wepamba, North America, Europe, India, Russia, Korea, Japan, Australia, nezvimwe.

Zvakanakira?Hunhu hwepamusoro, mutengo unokwanisika, masevhisi ehunyanzvi uye rutsigiro rwehunyanzvi, kuendesa nekukurumidza.

HunhuSimbiso?Strict quality control system.Midziyo yehunyanzvi yekuongorora inosanganisira NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, nezvimwe.

Samples?Zvigadzirwa zvakawanda zvinopa mahara emahara ekuongorora kwemhando, mutengo wekutumira unofanirwa kubhadharwa nevatengi.

Factory Audit?Factory audit inogamuchirwa.Ndapota itai nguva isati yasvika.

MOQ?Hapana MOQ.Kurongeka kudiki kunogamuchirwa.

Delivery Nguva? Kana mukati me stock, mazuva matatu kutumirwa anovimbiswa.

Transportation?Ne Express (FedEx, DHL), neMhepo, neGungwa.

Zvinyorwa?Mushure mekutengesa sevhisi: COA, MOA, ROS, MSDS, nezvimwe zvinogona kupihwa.

Custom Synthesis?Inogona kupa echinyakare synthesis masevhisi kuti aenderane nezvinodiwa zvako zvekutsvagisa.

Payment Terms?Proforma invoice inozotumirwa kutanga mushure mekusimbisa kurongeka, yakavharirwa ruzivo rwedu rwebhangi.Kubhadhara neT/T (Telex Transfer), PayPal, Western Union, nezvimwe.

Application:

6-Nitroindazole (CAS: 7597-18-4) inoshandiswa semishonga yepakati, Axitinib/AG013736 Pakati.Axitinib (AG-013736) inonzi multi-target inhibitor yeVEGFR1, VEGFR2, VEGFR3, PDGFRβ uye c-Kit ine IC50 ye0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM uye 1.7 nM, maererano.Axitinib inonzi tyrosine kinase inhibitor.Axitinib inoshandiswa mukurapa kenza.Muna Ndira 2012, US FDA yakabvumidza axitinib (inonziwo AG-013736) kuti irapwe advanced renal cell carcinoma (RCC) kuvarwere vasina kupindura kurapwa kwekare.Axitinib ipani VEGF inhibitor uye inoshanda nekusunga kune intracellular tyrosine kinase catalytic domain yeVEGF inotungamira kuvharika kwekusaina kuburikidza neiyi angiogenic nzira.